ASHOKLEY.BO
Ashok Leyland Limited
BSEINREQUITY
DELAYED
Last price
173.00
▼ 0.10 (0.06%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
173.00
Prev close
173.10
Day high
173.65
Day low
172.30
Volume
199.62K
Market cap
—
P/E (TTM)
—
52W range
95.20 – 205.20
Day trading desk
Gap from prior close
—
—
VWAP
173.02
-0.01% from price
Relative volume
—
—
Session range
0.78%
172.30 – 173.65
Position in range
52%
Mid range
ATR (14D)
—
Daily true range
Prior day high
—
PDH
Prior day low
—
PDL
Bid / ask spread
—
Quote not published
Session volume
184.28K
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Free account
3 more panels on ASHOKLEY.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $560.76B | $483.42B | $455.17B | $414.88B | +16.0% |
| Operating revenue | $560.76B | $483.42B | $455.17B | $414.88B | +16.0% |
| Cost of revenue | $339.64B | $297.82B | $293.47B | $289.36B | +14.0% |
| Gross profit | $221.12B | $185.60B | $161.71B | $125.53B | +19.1% |
| Research & development | $2.00B | $1.59B | $1.33B | $1.41B | +25.7% |
| Selling, general & admin | $12.67B | $9.18B | $7.28B | $6.84B | +38.0% |
| Total operating expense | $111.11B | $97.87B | $86.69B | $77.13B | +13.5% |
| Operating income | $110.01B | $87.73B | $75.01B | $48.39B | +25.4% |
| Net interest income | -$44.86B | -$38.36B | -$29.03B | -$20.62B | -16.9% |
| Pre-tax income | $51.55B | $45.96B | $41.06B | $22.65B | +12.2% |
| Tax provision | $14.34B | $12.14B | $14.10B | $9.06B | +18.2% |
| Net income | $34.71B | $31.07B | $24.84B | $12.39B | +11.7% |
| Net income to common | $34.71B | $31.07B | $24.84B | $12.39B | +11.7% |
| EBIT | $98.59B | $85.27B | $70.88B | $43.58B | +15.6% |
| EBITDA | $109.97B | $96.13B | $80.16B | $52.59B | +14.4% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $62.81B | $65.45B | $52.17B | $19.09B | -4.0% |
| Cash & short-term investments | $170.06B | $118.61B | $66.04B | $61.47B | +43.4% |
| Accounts receivable | $30.87B | $33.47B | $38.98B | $41.87B | -7.8% |
| Inventory | $46.72B | $39.86B | $40.08B | $34.40B | +17.2% |
| Total current assets | $437.42B | $342.40B | $291.27B | $242.43B | +27.8% |
| Property, plant & equipment | $85.36B | $66.50B | $59.74B | $59.02B | +28.4% |
| Goodwill & intangibles | $28.43B | $27.66B | $25.34B | $25.12B | +2.8% |
| Total assets | $1.01T | $817.15B | $675.96B | $547.46B | +23.7% |
| Total current liabilities | $331.18B | $265.51B | $266.80B | $224.55B | +24.7% |
| Current debt | $176.33B | $133.18B | $138.69B | $114.18B | +32.4% |
| Long-term debt | $460.16B | $363.83B | $266.96B | $195.03B | +26.5% |
| Total debt | $639.36B | $499.62B | $408.02B | $311.61B | +28.0% |
| Total liabilities | $824.95B | $658.70B | $557.81B | $439.50B | +25.2% |
| Retained earnings | $76.82B | $63.58B | $37.73B | $37.17B | +20.8% |
| Shareholder equity | $142.42B | $122.32B | $90.05B | $85.52B | +16.4% |
| Working capital | $106.25B | $76.89B | $24.47B | $17.88B | +38.2% |
| Net tangible assets | $113.99B | $94.66B | $64.71B | $60.39B | +20.4% |
| Shares issued | 5.87B | 5.87B | 5.87B | 5.87B | +0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $37.21B | $33.83B | $26.96B | $13.59B | +10.0% |
| Depreciation & amortisation | $11.38B | $10.87B | $9.27B | $9.00B | +4.7% |
| Stock-based compensation | -$289.80M | $138.20M | $86.30M | $35.40M | -309.7% |
| Change in working capital | -$111.05B | -$51.66B | -$113.35B | -$72.61B | -115.0% |
| Operating cash flow | -$48.95B | $1.28B | -$62.58B | -$44.99B | -3,910.0% |
| Capital expenditure | -$29.45B | -$16.48B | -$11.34B | -$9.29B | -78.7% |
| Investing cash flow | -$70.16B | -$57.58B | $11.35B | -$29.35B | -21.8% |
| Dividends paid | -$18.35B | -$20.41B | -$7.63B | -$2.94B | +10.1% |
| Financing cash flow | $116.17B | $69.58B | $84.32B | $72.81B | +67.0% |
| Free cash flow | -$78.40B | -$15.20B | -$73.92B | -$54.28B | -415.9% |
| End cash position | $62.81B | $65.45B | $52.17B | $19.09B | -4.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $171.39B | $147.62B | $125.18B | $116.57B | $146.37B | +16.1% |
| Operating revenue | $171.39B | $147.62B | $125.18B | $116.57B | $146.37B | +16.1% |
| Cost of revenue | $107.32B | $89.76B | $73.53B | $67.95B | $90.07B | +19.6% |
| Gross profit | $64.07B | $57.86B | $51.66B | $48.61B | $56.30B | +10.7% |
| Total operating expense | $32.06B | $28.83B | $26.47B | $26.42B | $28.00B | +11.2% |
| Operating income | $32.01B | $29.03B | $25.18B | $22.19B | $28.30B | +10.2% |
| Net interest income | -$12.41B | -$12.00B | -$11.52B | -$11.12B | -$10.53B | -3.4% |
| Pre-tax income | $19.40B | $12.00B | $11.24B | $8.91B | $16.21B | +61.7% |
| Tax provision | $5.58B | $3.37B | $3.04B | $2.34B | $3.75B | +65.5% |
| Net income | $12.91B | $8.13B | $7.56B | $6.11B | $11.30B | +58.7% |
| Net income to common | $12.91B | $8.13B | $7.56B | $6.11B | $11.30B | +58.7% |
| EBIT | $31.80B | $24.00B | $22.76B | $20.03B | $26.73B | +32.5% |
| EBITDA | $34.94B | $26.82B | $25.44B | $22.77B | $30.13B | +30.3% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $62.81B | $47.07B | $65.45B | +33.4% |
| Cash & short-term investments | $170.06B | $101.41B | $118.61B | +67.7% |
| Accounts receivable | $30.87B | $34.07B | $33.47B | -9.4% |
| Inventory | $46.72B | $46.11B | $39.86B | +1.3% |
| Total current assets | $437.42B | $343.30B | $342.40B | +27.4% |
| Property, plant & equipment | $85.36B | $77.11B | $66.50B | +10.7% |
| Goodwill & intangibles | $28.43B | $28.30B | $27.66B | +0.5% |
| Total assets | $1.01T | $853.10B | $817.15B | +18.4% |
| Total current liabilities | $331.18B | $254.52B | $265.51B | +30.1% |
| Current debt | $176.33B | $141.82B | $133.18B | +24.3% |
| Long-term debt | $460.16B | $400.82B | $363.83B | +14.8% |
| Total debt | $639.36B | $545.13B | $499.62B | +17.3% |
| Total liabilities | $824.95B | $686.85B | $658.70B | +20.1% |
| Retained earnings | $76.82B | — | $63.58B | — |
| Shareholder equity | $142.42B | $125.83B | $122.32B | +13.2% |
| Working capital | $106.25B | $88.78B | $76.89B | +19.7% |
| Net tangible assets | $113.99B | $97.53B | $94.66B | +16.9% |
| Shares issued | 5.87B | 5.87B | 5.87B | +0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
—
5Y monthly, from filing
Headlines
1 Reason Why Meta Might Be the Best Artificial Intelligence (AI) Stock to Buy and Hold for 5 Years and Beyond
Motley Fool · 6m ago
Citi expects Nvidia stock to trade higher post earnings
Investing.com · 9m ago
Microsoft Stock Dropped 30% From Its All-Time High: 2 Reasons It Could Double by 2030
Motley Fool · 12m ago
Humanoids break records at Beijing Robot Games
AFP · 13m ago
Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
Motley Fool · 14m ago
Why Tempus AI Skyrocketed This Week
Motley Fool · 21m ago
If Amazon Is a Top Growth Stock, Then Why Does It Trade at Just 21.3x Forward Earnings While the S&P 500 Trades at 20.4x? This Is the Only Answer I Can Think Of.
Motley Fool · 21m ago
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
Motley Fool · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.